Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigid S Boland

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Inflammatory Bowel Diseases|April 27, 2018
Efficacy and Safety of Endoscopic Balloon Dilatation of Ileoanal Pouch StricturesMathurin Fumery, Niraj S Patel, Brigid S Boland, et al.
Inflammatory Bowel Diseases|November 22, 2019
Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative ColitisNghia H Nguyen, Soumya Kurnool, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2019
Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseasesSiddharth Singh, Parambir S Dulai, Niels Vande Casteele, et al.
Inflammatory Bowel Diseases|October 14, 2020
National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United StatesNghia H Nguyen, Rohan Khera, Parambir S Dulai, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
A Living Organoid Biobank of Crohn's Disease Patients Reveals Distinct Clinical Correlates of Molecular Subtypes of DiseaseHarrison M Penrose, Saptarshi Sinha, Courtney Tindle, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 10, 2026
New Approach Methodologies in Crohn's Disease Link Molecular Disease Subtypes to Clinical OutcomesHarrison M Penrose, Saptarshi Sinha, Courtney Tindle, et al.
Alimentary Pharmacology & Therapeutics|December 11, 2024
Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative ColitisAustin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, et al.
Inflammatory Bowel Diseases|November 25, 2020
Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic RemissionHyuk Yoon, Sushrut Jangi, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|November 30, 2020
Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset DiseaseJacob J Rozich, Jiyu Luo, Parambir S Dulai, et al.
Digestive Diseases and Sciences|October 27, 2018
Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Nghia H Nguyen, Brigid S Boland, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Inflammatory Bowel Diseases|April 27, 2018
Efficacy and Safety of Endoscopic Balloon Dilatation of Ileoanal Pouch StricturesMathurin Fumery, Niraj S Patel, Brigid S Boland, et al.
Inflammatory Bowel Diseases|November 22, 2019
Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative ColitisNghia H Nguyen, Soumya Kurnool, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2019
Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseasesSiddharth Singh, Parambir S Dulai, Niels Vande Casteele, et al.
Inflammatory Bowel Diseases|October 14, 2020
National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United StatesNghia H Nguyen, Rohan Khera, Parambir S Dulai, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
A Living Organoid Biobank of Crohn's Disease Patients Reveals Distinct Clinical Correlates of Molecular Subtypes of DiseaseHarrison M Penrose, Saptarshi Sinha, Courtney Tindle, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 10, 2026
New Approach Methodologies in Crohn's Disease Link Molecular Disease Subtypes to Clinical OutcomesHarrison M Penrose, Saptarshi Sinha, Courtney Tindle, et al.
Alimentary Pharmacology & Therapeutics|December 11, 2024
Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative ColitisAustin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, et al.
Inflammatory Bowel Diseases|November 25, 2020
Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic RemissionHyuk Yoon, Sushrut Jangi, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|November 30, 2020
Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset DiseaseJacob J Rozich, Jiyu Luo, Parambir S Dulai, et al.
Digestive Diseases and Sciences|October 27, 2018
Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Nghia H Nguyen, Brigid S Boland, et al.
Pageof 10